W1M Asset Management Ltd purchased a new position in Abbott Laboratories (NYSE:ABT – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,504 shares of the healthcare product maker’s stock, valued at approximately $590,000. Several other institutional investors and hedge funds […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.